OR WAIT 15 SECS
Tina S. Morris, PhD, is vice president of Biologics & Biotechnology at United States Pharmacopeia (USP)
November 02, 2015
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
March 02, 2015
A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
September 02, 2012
USP optimizes identification tests and impurities procedures.
August 02, 2011
USP promotes horizontal standards for biologics' quality attributes.